PHASE III RANDOMIZED CONTROLLED TRIAL TO COMPARE BIOSIMILAR INFLIXIMAB (CT-P13) WITH INNOVATOR INFLIXIMAB IN PATIENTS WITH ACTIVE CROHN’S DISEASE: 1-YEAR MAINTENANCE AND SWITCHING RESULTS
Young-Ho Kim 1
Byong Duk Ye 2
Marina Pesegova 3
Olga Alexeeva 4
Marina Osipenko 5
Adi Lahat 6
Andriy Dorofeyev
Ágnes Szabone Salamon
Sigal Fishman
Olena Levchenko
Jae Hee Cheon
Maria Lia Scribano
Radu-Bogdan Mateescu
Kang Moon Lee
Chang Soo Eun
Sang Joon Lee
Sung Young Lee
Alex Kudrin
1 Samsung Medical Center,Seoul,Korea, Republic of
2 Asan Medical Center,Seoul,Korea, Republic of
3 Krasnoyarsk Regional clinical hospital,Krasnoyarsk,Russian Federation
4 Nizhny Novgorod Regional Clinical Hospital,Nizhny Novgorod,Russian Federation
5 Novosibirsk State Medical University,Novosibirsk,Russian Federation
6 Sheba Medical Center,D
Conference
25th UEG Week 2017
Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at office@ueg.eu